Darius M. Moshfeghi

Publication Details

  • 24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomes.

    Canton VM, Quiroz-Mercado H, Velez-Montoya R, Lopez-Miranda MJ, Moshfeghi AA, Shusterman EM, Kaiser PK, Sanislo SR, Gertner M, Moshfeghi DM. Ophthalmic Surg Lasers Imaging. 2012 Jan-Feb; 43 (1): 20-4

    To describe the 6-month safety and preliminary efficacy outcomes of the use of 24-Gy radiation with intravitreal ranibizumab for patients with neovascular age-related macular degeneration (AMD).

    PubMedID: 22251841

Stanford Medicine Resources:

Footer Links: